Skip to content
Screener

SELLAS Life Sciences Group, Inc. SLS Q4 2025 Annual earnings

Reported March 19, 2026 · Before market open

EPS-$0.05Beat by $0.01
EPS estimate-$0.06

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.05

Financials

Q4 2025

Income statement

See full
Operating income-$8.3M-19.3%
Net income-$7.7M-13.7%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$71.8M+417%
Total debt$1.0M0.0%
Total equity$70.9M+649%
Total assets$78.3M+303%

Cash flow

See full
Operating cash flow-$4.9M+31.2%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$537.01M+634%
Enterprise value$466.22M+673%

Returns & leverage

See full
Return on equity-66.9%—
Debt / equity0×-0.1×
Current ratio10.7×+9.0×

FAQ

When did SELLAS Life Sciences Group, Inc. report Q4 2025 earnings?
SELLAS Life Sciences Group, Inc. (SLS) reported Q4 2025 earnings on March 19, 2026 before market open.
What were SELLAS Life Sciences Group, Inc.'s Q4 2025 revenue and EPS?
SELLAS Life Sciences Group, Inc. reported eps of $-0.05 for Q4 2025.
Did SELLAS Life Sciences Group, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.06 by $0.01.
How did SELLAS Life Sciences Group, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 37.5% from $-0.08.
Where can I find SELLAS Life Sciences Group, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001390478-26-000004) and the 10-K periodic report (0001390478-26-000003) directly on SEC EDGAR. The filing index links above go to sec.gov.